These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 989797
1. The Walton report. Danilevicius Z. JAMA; 1976 Nov 01; 236(18):2098-9. PubMed ID: 989797 [No Abstract] [Full Text] [Related]
2. Editorial: Walton report on cervical screening. Lancet; 1976 Jun 19; 1(7973):1337. PubMed ID: 58323 [No Abstract] [Full Text] [Related]
3. The Walton report and its subsequent impact on cervical cancer screening programs in Canada. Worth AJ. Obstet Gynecol; 1984 Feb 19; 63(2):135-9. PubMed ID: 6694805 [Abstract] [Full Text] [Related]
4. Impact of the Walton report on cervical cancer screening programs in Canada. Kassirer E. Can Med Assoc J; 1980 Feb 23; 122(4):417-23. PubMed ID: 7370844 [Abstract] [Full Text] [Related]
5. Cervical cancer screening: précis and critique of a recent Canadian report. Chiavetta J, Leader SR. Med J Aust; 1980 Feb 23; 1(1-2):23-8. PubMed ID: 840075 [No Abstract] [Full Text] [Related]
6. An analysis of the prevalence and incidence of gynecologic cancer cytologically detected in a population of 175,767 women. Kasper TA, Smith ES, Cooper P, Clayton J, Todd D. Acta Cytol; 1970 May 23; 14(5):261-9. PubMed ID: 5284264 [No Abstract] [Full Text] [Related]
7. Quality control mechanism for cytology programs. Wied GL. Acta Cytol; 1965 May 23; 9(6):407-12. PubMed ID: 5218350 [No Abstract] [Full Text] [Related]
8. [MASS CYTOLOGICAL TESTS IN CANADA AND THE USA]. CLEMMESEN J. Ugeskr Laeger; 1964 Jan 16; 126():82-4. PubMed ID: 14115394 [No Abstract] [Full Text] [Related]
9. [10-year cytodiagnosis of cervical carcinoma: results and further developments]. Wagner D. Geburtshilfe Frauenheilkd; 1966 Aug 16; 26(8):1135-44. PubMed ID: 5990257 [No Abstract] [Full Text] [Related]
10. Time trends in cervical cancer screening rates in the OECD countries. Machii R, Saito H. Jpn J Clin Oncol; 2011 May 16; 41(5):731-2. PubMed ID: 21536695 [No Abstract] [Full Text] [Related]
11. Results from a cervical cancer screening programme in Manitoba, Canada. Choi NW, Nelson NA. IARC Sci Publ; 1986 May 16; (76):61-7. PubMed ID: 3570416 [No Abstract] [Full Text] [Related]
12. Evaluation of the impact of screening for cancer of the cervix. Miller AB. IARC Sci Publ; 1986 May 16; (76):149-60. PubMed ID: 3570400 [No Abstract] [Full Text] [Related]
13. Frequency of cervical cancer screening by age group, 2000. J Natl Cancer Inst; 2002 Jun 19; 94(12):879. PubMed ID: 12072540 [No Abstract] [Full Text] [Related]
14. Global gleanings. Isbell NP. Acta Cytol; 1970 May 19; 14(5):237-8. PubMed ID: 5284261 [No Abstract] [Full Text] [Related]
15. Progress in screening for cervical cancer. Stuart GC, Krepart GV, Drouin P, Paraskevas M. CMAJ; 1996 Oct 15; 155(8):1037. PubMed ID: 8873624 [No Abstract] [Full Text] [Related]
16. [Importance of cytological study in mass screening]. Anfinogenova LV, Zanina NN, Kobkina TG, Kostyleva IV, Mordovskaia LI. Sov Med; 1977 Mar 15; (3):137-40. PubMed ID: 867085 [No Abstract] [Full Text] [Related]
17. The epidemiological basis for evaluating different screening policies. Day NE. IARC Sci Publ; 1986 Mar 15; (76):199-212. PubMed ID: 3570405 [No Abstract] [Full Text] [Related]
18. Cancer of the cervix: death by incompetence. Lancet; 1985 Sep 14; 2(8455):603-4. PubMed ID: 2863608 [No Abstract] [Full Text] [Related]
19. [The importance of cytodiagnosis in the detection of cancer of the uterine cervix prophylactic examinations]. Skoblia ES, Korshun KZ. Vopr Onkol; 1969 Sep 14; 15(1):67-70. PubMed ID: 5784521 [No Abstract] [Full Text] [Related]
20. Mortality from cervical cancer: can it be prevented now? Kessler II. Compr Ther; 1976 Sep 14; 2(9):38-47. PubMed ID: 963967 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]